Earnings Call
AbbVie Inc. (ABBV) Q4 2023 Earnings Call Transcript
Presentations
company representative·Additional Participants
company representative
Liz Shea - Vice President of Investor Relations
Rick Gonzalez - Chairman of the Board & Chief Executive Officer
Rob Michael - President & Chief Operating Officer
Jeff Stewart - Executive Vice President & Chief Commercial Officer
Carrie Strom - Senior Vice President, AbbVie and President, Global Allergan Aesthetics
Roopal Thakkar - SVP, Development & Regulatory Affairs & Chief Medical Officer
Scott Reents - Executive Vice President & Chief Financer
Tom Hudson - Senior Vice President, R&D & Chief Scientific Officer
Additional Participants
Chris Schott - JPMorgan
Terence Flynn - Morgan Stanley
Andrew Baum - Citigroup
Mohit Bansal - Wells Fargo
Carter Gould - Barclays
Gary Nachman - Raymond James
Steve Scala - TD Cowen
Tim Anderson - Wolfe Research
Tim Lugo - William Blair
James Shin - Deutsche Bank
David Risinger - Leerink Partners
Luisa Hector - Berenberg
Operator
Good morning, and thank you for standing by. Welcome to the AbbVie Fourth Quarter 2023 Earnings Conference Call. All participants will be able to listen-only until the question-and-answer portion of this call. [Operator Instructions] Today's call is also being recorded. If you have any objection, you may disconnect at this time.
I would now like to introduce Ms. Liz Shea, Senior Vice President, Investor Relations. Thank you. You may begin.
I would now like to introduce Ms. Liz Shea, Senior Vice President, Investor Relations. Thank you. You may begin.
Liz Shea
Good morning, and thanks for joining us. Also on the call with me today are Rick Gonzalez, Chairman of the Board and Chief Executive Officer; Rob Michael, President and Chief Operating Officer; Jeff Stewart, Executive Vice President, Chief Commercial Officer; Scott Reents, Executive Vice President, Chief Financial Officer; Carrie Strom, Senior Vice President, AbbVie and President, Global Allergan Aesthetics; and Roopal Thakkar, Senior Vice President, Chief Medical Officer, Global Therapeutics. Joining us for the Q&A portion of the call is Tom Hudson, Senior Vice President, Chief Scientific Officer, Global Research.